A cloud-based digital health navigation program for colorectal cancer screening

基于云的结直肠癌筛查数字健康导航程序

基本信息

项目摘要

Over 30% of age-eligible Americans fail to receive recommended screening for colorectal cancer (CRC), the second leading cause of cancer death in the United States. Multilevel barriers explain why so many Americans fail to receive routine CRC screening. Patients report a lack of knowledge about the need for screening or their screening options, and many view screening as messy, uncomfortable, or embarrassing. Busy clinicians report a lack of time to deliver preventive care, and many clinicians only discuss colonoscopy. Lastly, healthcare systems lack strategies to reach out to patients independent of a scheduled medical visit. Disruptions caused by COVID19 also have led to a decrease in the use of preventive services. To address these multilevel barriers, our team has developed and tested a tablet-based digital health navigator for colorectal cancer screening called mPATH™ (mobile Patient Technology for Health). mPATH™ determines if patients are due for CRC screening, educates them about their options, and lets them request a screening test directly via the program. In a randomized controlled trial conducted in primary care practices, mPATH™ doubled the proportion of patients who completed CRC screening and had excellent usability ratings. However, we have learned that our tablet-based model of mPATH™ is difficult to scale as it requires on-site training and changes to workflows. The goal of this Fast Track STTR proposal is to develop and test a cloud-based version of mPATH™ that patients can use at home independent of a scheduled medical visit. Patients will access mPATH™ on their own devices using a hyperlink sent via text message or patient portal. The cloud version of mPATH™ will have the proven effective content of the tablet version, including the ability to request a screening test directly via the program. mPATH™ will then share this information with the patient’s healthcare organization so screening can be arranged. This cloud-based version will be highly scalable, have broad reach, and be easy to support, making it a commercially viable product. To accomplish this goal, the work of this proposal will: (1) create a culturally appropriate and engaging cloud-based version of mPATH™ by leveraging input from community members, an expert Scientific Advisory Committee, and feedback from users; (2) determine the feasibility of the cloud-based mPATH™-CRC web app in a highly pragmatic pilot trial conducted in a large health system; (3) test the reach and effectiveness of the mPATH™ web app in two different healthcare settings: a large health system, and an Accountable Care Organization that includes rural Federally Qualified Health Centers; and (4) determine the value generated by mPATH™ in each healthcare setting. This Fast Track STTR will provide information that is critical to mPATH™’s future commercialization by demonstrating its reach into diverse populations, its effectiveness in increasing screening, and the value it generates to potential future customers. If successful, mPATH™ will fill a critical need for a commercially available, easily scalable solution for colorectal cancer screening and potentially other preventive services.
超过30%的年龄符合年龄的美国人未能接受建议的结直肠癌筛查(CRC),即 美国癌症死亡的第二大原因。多层障碍解释了为什么这么多美国人 无法接受常规的CRC筛查。患者报告缺乏有关筛查或他们的需求的知识 筛选选项,许多将筛选视为凌乱,不舒服或令人尴尬的筛查。忙碌的临床医生报告 缺乏提供预防性护理的时间,许多临床医生只讨论结肠镜检查。最后,医疗保健 系统缺乏与预定医疗访问无关的患者接触的策略。造成了干扰 到Covid19还导致预防服务的使用减少。解决这些多级 障碍,我们的团队已经开发并测试了基于平板电脑的大肠癌的数字健康导航器 筛选称为MPATH™(健康的移动患者技术)。 MPATH™确定患者是否到期 对于CRC筛查,请他们对他们的选择进行教育,并让他们直接通过 程序。在初级保健实践中进行的随机对照试验中,MPATH™将 完成CRC筛查并且具有出色可用性评级的患者比例。但是,我们有 了解到,我们基于平板电脑的MPATH™模型很难扩展,因为它需要现场培训和更改 工作流程。这个快速轨道sttr提案的目的是开发和测试基于云的版本的 患者可以独立于预定的医疗访问,患者可以在家中使用。患者将进入 MPATH™在自己的设备上使用通过短信或患者门户发送的超链接。云版本的 MPATH™将具有平板电脑版本的有效内容,包括请求 直接通过程序筛选测试。然后,MPATH™将与患者的医疗保健共享此信息 组织可以安排筛查。这个基于云的版本将具有很高的可扩展性,具有广泛的 到达,易于支撑,使其成为商业上可行的产品。为了实现这一目标, 该提案将:(1)创建一个文化适当且引人入胜的基于云的Mathe™。 利用社区成员,专家科学咨询委员会的意见以及用户的反馈; (2)在高度务实的试点试验中确定基于云的MPATH™-CRC Web应用程序的可行性 在大型卫生系统中进行; (3)在两个中测试MPATH™Web应用程序的覆盖范围和有效性 不同的医疗保健环境:一个大型卫生系统,以及包括农村在内的负责任组织 联邦资格卫生中心; (4)确定MPATH™在每个医疗保健中产生的价值 环境。这种快速轨道的sttr将提供对Math™未来商业化至关重要的信息 证明其进入潜水员人群,在增加筛查方面的有效性以及IT的价值 生成潜在的未来客户。如果成功,MPATH™将满足商业上的关键需求 可用的,易于扩展的结论直肠癌筛查和其他预防服务的解决方案。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

David P Miller其他文献

Color Doppler and two-dimensional echocardiographic determination of the mechanism of aortic regurgitation with surgical correlation.
彩色多普勒和二维超声心动图测定主动脉瓣关闭不全的机制与手术的相关性。
Reduction in complications of angioplasty with abciximab occurs largely independently of baseline lesion morphology. EPIC and EPILOG Investigators. Evaluation of 7E3 for the Prevention of Ischemic Complications. Evaluation of PTCA To Improve Long-term Outcome with abciximab GPIIb/IIIa Receptor Block
阿昔单抗对血管成形术并发症的减少很大程度上与基线病变形态无关。
  • DOI:
    10.1016/s0735-1097(98)00403-3
  • 发表时间:
    1998
  • 期刊:
  • 影响因子:
    24
  • 作者:
    Stephen G. Ellis;A. Lincoff;David P Miller;J. Tcheng;N. Kleiman;D. Kereiakes;R. Califf;E. Topol
  • 通讯作者:
    E. Topol
Long‐Term Protection from Myocardial Ischemic Events in a Randomized Trial of Brief Integrin β3 Blockade with Percutaneous Coronary Intervention
经皮冠状动脉介入治疗短暂整合素 β3 阻断的随机试验对心肌缺血事件的长期保护
  • DOI:
    10.1097/00132586-199808000-00009
  • 发表时间:
    1998
  • 期刊:
  • 影响因子:
    0
  • 作者:
    E. Topol;J. Ferguson;H. Weisman;J. Tcheng;S. Ellis;N. Kleiman;R. Ivanhoe;Ann L. Wang;David P Miller;K. Anderson;R. Califf
  • 通讯作者:
    R. Califf
Benefit of early sustained reperfusion in patients with prior myocardial infarction (the GUSTO-I trial). Global Utilization of Streptokinase and TPA for occluded arteries.
早期持续再灌注对既往心肌梗塞患者的益处(GUSTO-I 试验)。
  • DOI:
  • 发表时间:
    1998
  • 期刊:
  • 影响因子:
    2.8
  • 作者:
    D. Brieger;K. Mak;H. White;N. Kleiman;David P Miller;A. Vahanian;A. Ross;R. Califf;E. Topol
  • 通讯作者:
    E. Topol
Long-term protection from myocardial ischemic events in a randomized trial of brief integrin beta3 blockade with percutaneous coronary intervention. EPIC Investigator Group. Evaluation of Platelet IIb/IIIa Inhibition for Prevention of Ischemic Complication.
在一项短期整合素 β3 阻断联合经皮冠状动脉介入治疗的随机试验中,可长期预防心肌缺血事件。
  • DOI:
  • 发表时间:
    1997
  • 期刊:
  • 影响因子:
    0
  • 作者:
    E. Topol;J. Ferguson;H. Weisman;J. Tcheng;Stephen G. Ellis;N. Kleiman;R. Ivanhoe;Ann L. Wang;David P Miller;K. Anderson;R. Califf
  • 通讯作者:
    R. Califf

David P Miller的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('David P Miller', 18)}}的其他基金

Effectiveness and Implementation of mPATH-CRC: a Mobile Health System for Colorectal Cancer Screening
mPATH-CRC 的有效性和实施:用于结直肠癌筛查的移动医疗系统
  • 批准号:
    10165873
  • 财政年份:
    2020
  • 资助金额:
    $ 39.8万
  • 项目类别:
A Personalized Digital Outreach Intervention for Lung Cancer Screening
肺癌筛查的个性化数字外展干预措施
  • 批准号:
    10551856
  • 财政年份:
    2020
  • 资助金额:
    $ 39.8万
  • 项目类别:
A Personalized Digital Outreach Intervention for Lung Cancer Screening
肺癌筛查的个性化数字外展干预措施
  • 批准号:
    10318171
  • 财政年份:
    2020
  • 资助金额:
    $ 39.8万
  • 项目类别:
A Personalized Digital Outreach Intervention for Lung Cancer Screening
肺癌筛查的个性化数字外展干预措施
  • 批准号:
    10062917
  • 财政年份:
    2020
  • 资助金额:
    $ 39.8万
  • 项目类别:
A Personalized Digital Outreach Intervention for Lung Cancer Screening
肺癌筛查的个性化数字外展干预措施
  • 批准号:
    9885242
  • 财政年份:
    2020
  • 资助金额:
    $ 39.8万
  • 项目类别:
Effectiveness and Implementation of mPATH-CRC: a Mobile Health System for Colorectal Cancer Screening
mPATH-CRC 的有效性和实施:用于结直肠癌筛查的移动医疗系统
  • 批准号:
    9895633
  • 财政年份:
    2018
  • 资助金额:
    $ 39.8万
  • 项目类别:
Effectiveness and Implementation of mPATH-CRC: a Mobile Health System for Colorectal Cancer Screening
mPATH-CRC 的有效性和实施:用于结直肠癌筛查的移动医疗系统
  • 批准号:
    10116309
  • 财政年份:
    2018
  • 资助金额:
    $ 39.8万
  • 项目类别:
Effectiveness and Implementation of mPATH-CRC: a Mobile Health System for Colorectal Cancer Screening
mPATH-CRC 的有效性和实施:用于结直肠癌筛查的移动医疗系统
  • 批准号:
    10382400
  • 财政年份:
    2018
  • 资助金额:
    $ 39.8万
  • 项目类别:
Institutional Career Development Core
机构职业发展核心
  • 批准号:
    10440530
  • 财政年份:
    2015
  • 资助金额:
    $ 39.8万
  • 项目类别:
Institutional Career Development Core
机构职业发展核心
  • 批准号:
    9902913
  • 财政年份:
    2015
  • 资助金额:
    $ 39.8万
  • 项目类别:

相似国自然基金

成人型弥漫性胶质瘤患者语言功能可塑性研究
  • 批准号:
    82303926
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
  • 批准号:
    82302160
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
  • 批准号:
    82302025
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
融合多源异构数据应用深度学习预测成人肺部感染病原体研究
  • 批准号:
    82302311
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Implementing SafeCare Kenya to Reduce Noncommunicable Disease Burden: Building Community Health Workers' Capacity to Support Parents with Young Children
实施 SafeCare Kenya 以减少非传染性疾病负担:建设社区卫生工作者支持有幼儿的父母的能力
  • 批准号:
    10672785
  • 财政年份:
    2023
  • 资助金额:
    $ 39.8万
  • 项目类别:
Fecal Microbiota Transfer Attenuates Aged Gut Dysbiosis and Functional Deficits after Traumatic Brain Injury
粪便微生物群转移可减轻老年肠道菌群失调和脑外伤后的功能缺陷
  • 批准号:
    10573109
  • 财政年份:
    2023
  • 资助金额:
    $ 39.8万
  • 项目类别:
Planning and Evaluation Core
规划与评估核心
  • 批准号:
    10762147
  • 财政年份:
    2023
  • 资助金额:
    $ 39.8万
  • 项目类别:
Characterizing the genetic etiology of delayed puberty with integrative genomic techniques
利用综合基因组技术表征青春期延迟的遗传病因
  • 批准号:
    10663605
  • 财政年份:
    2023
  • 资助金额:
    $ 39.8万
  • 项目类别:
Mentoring the next generation of trainees in patient-oriented, community engaged research in obesity and health equity
指导下一代学员进行以患者为中心、社区参与的肥胖和健康公平研究
  • 批准号:
    10662072
  • 财政年份:
    2023
  • 资助金额:
    $ 39.8万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了